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The single pass, transmembrane proteins of the cadherin family have been appreciated 
as important proteins that regulate intercellular adhesion. In addition to this critical function, 
cadherins contribute to important signaling events that control cellular homeostasis. Many 
examples exist of classical, desmosomal, and atypical cadherins participating in the 
regulation of signaling events that control homeostatic functions in cells. Much of the work 
on cadherin mediated signaling focuses on classical cadherins or on specific disease states 
such as pemphigus vulgaris. Cadherin mediated signaling has been shown to play critical 
roles during development, in proliferation, apoptosis, disease pathobiology, and beyond. It is 
becoming increasingly clear that cadherins operate through a range of molecular mechanisms. 
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only scratched the surface in terms of the roles that these versatile proteins play in signaling 




Cadherins serve as calcium dependent transmembrane adhesion proteins and are 
subdivided into classical-, proto-, desmosomal, and atypical cadherins  (Harris & Tepass, 
2010). The classical and desmosomal cadherins have an ectodomain composed of five 
extracellular cadherin repeats, a single transmembrane region, and a cytoplasmic domain that 
interacts with either β-catenin (classical cadherins) or plakoglobin (Pg) (desmosomal and 
classical cadherins) (Shapiro & Weis, 2009). In addition to the classical adhesive function of 
cadherins, they contribute to a number of other cellular processes including cellular signaling 
(Kovacs, 2003; Wheelock & Johnson, 2003; Heuberger & Birchmeier, 2010). Dynamic 
changes in cell adhesion are needed to establish and re-establish cell-cell contacts in multiple 
contexts, including developmental cell movements, tissue renewal, and wound repair (Harris 
& Tepass, 2010; Pandya et al., 2017). These processes require cells to integrate and process a 
variety of signals from the external- as well as the internal milieu (Table 1). In many cases, 
the precise mechanism by which the cadherins participate in a signaling pathway to influence 
cellular outcome is not fully understood, even though their involvement in the pathway is 
clearly demonstrated. One of the most well characterized signaling functions of cadherins is 
by acting as scaffolds to either promote or inhibit certain signaling pathways, which most 
often depend on the presence of the cadherin in the junction or its adhesion state. Through 
these and other mechanisms, cadherins participate in regulation of cellular homeostatic events 
that encompass proliferation, differentiation and apoptosis. For the purposes of this review, 




This article is protected by copyright. All rights reserved. 
 
 
differentiation of cells. We are also including mechanisms that that may be required for cells 
to maintain a homeostatic state (i.e. glucose metabolism) as “non-homeostatic” though they 
can play a role in homeostasis. In this review, we will discuss the emergence of distinct 
classes of cadherin mediated signaling mechanisms. Mechanisms that are directly dependent 
upon changes in the adhesion state or junctional residence of cadherins are discussed first. 
We will refer to these as adhesion or junctional residence dependent cadherin signaling 
mechanisms. Thereafter, mechanisms that are not themselves dependent upon a change in 
adhesion are discussed. 
 
A) Cadherin mediated regulation of proliferation  
Cadherins have been implicated in the regulation of cell proliferation through 
interaction with a wide range of signaling mediators. One example, and arguably the most 
classic paradigm of cadherin mediated signaling, is by modulating β-catenin signaling (Harris 
& Tepass, 2010; Clevers & Nusse, 2012). The classical cadherins E-cadherin, N-cadherin, 
and VE-cadherin can prevent nuclear localization of β-catenin by direct interaction, thereby 
inhibiting TCF/LEF mediated stimulation of proliferation (Solanas et al., 2008; Kourtidis et 
al., 2017). In addition to sequestration through direct binding, E-cadherin can suppress β-
catenin signaling through other mechanisms. For example, re-expression of E-cadherin in 
SW480 colon carcinoma cells leads to increased β-catenin phosphorylation and co-
localization at the plasma membrane with APC, thus promoting β-catenin degradation (Maher 
et al., 2009). Furthermore, the authors show that neither phosphorylated β-catenin nor 
members of the destruction complex co-fractionate with E-cadherin suggesting that 
regulation of β-catenin stability by E-cadherin can be independent of direct binding (Maher et 
al., 2009). However, another study found that re-expression of E-cadherin in this same cell 
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catenin nuclear localization via direct binding (Solanas et al., 2008). These data suggest that 
E-cadherin can regulate the function of β-catenin through multiple functionally distinct 
mechanisms within the same cell type.  Additionally, depending on the circumstances and the 
mechanism used, E-cadherin can either promote or repress β-catenin signaling and therefore 
proliferation. Such differences highlight the intricacies and complexities of cadherin 
mediated signaling.  Binding of E-cadherin to β-catenin also affects other signaling pathways 
in addition to TCF/LEF mediated transcriptional regulation. E-cadherin engagement directly 
regulates the Hippo signaling pathway in a β-catenin dependent manner through prevention 
of YAP nuclear localization, thereby inhibiting cell proliferation (Kim et al., 2011a). Howard 
et al. noted that when comparing two common model epithelial cell lines, MDCK and 
HEK293, MDCK cells are more classically “epithelial” and have well developed tight and 
adherens junctions, whereas the HEK293 cells lack such properties. Exposure of MDCK cells 
to hepatocyte growth factor (HGF) results in transition from the epithelial phenotype to one 
resembling HEK293s. While treatment of standard MDCK cells with Wnt3a does not 
noticeably affect β-catenin signaling, pretreatment with HGF (or treatment of HEK293 cells) 
increases β-catenin signaling compared to standard MDCK cells. E-cadherin knock-down in 
the HGF pretreated MDCK cells or in the HEK293 cells abolishes these signaling effects 
(Howard et al., 2011). These findings suggest that when epithelial cells transition to a more 
mesenchymal phenotype, the ability of Wnt ligands to activate β-catenin signaling is 
enhanced and this effect is dependent on E-cadherin. In light of the results discussed above, 
the outcome of E-cadherin on β-catenin signaling is dependent on whether or not the cells 
exhibit an epithelial- or a mesenchymal phenotype. During development several populations 
of cells undergo an epithelial to mesenchymal transition (EMT), including epiblast cells in 
the primitive streak(Yoshikawa et al., 1997; Chapman & Papaioannou, 1998). As part of this 
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cadherin with increased Wnt/β-catenin signaling that has been linked to differentiation of 
these migrated cells into the mesoderm. To test the functional relevance of their in vitro 
findings, the authors analyzed the levels of the Wnt/ β-catenin target gene Tbx6 (known to be 
important for the differentiation of migrated epiblasts into mesoderm) in N-cadherin knock-
out mouse embryos(Yoshikawa et al., 1997; Chapman & Papaioannou, 1998).  Reduced Tbx6 
expression was observed in these knock-out mice compared to controls, suggesting that 
cadherin mediated increase of Wnt/β-catenin signaling may be required for critical steps in 
embryonic development (Howard et al., 2011). Together, these data suggest that through 
modulation of β-catenin activity, E-cadherin can participate in a variety of signal transduction 
pathways that influences cellular outcomes. 
In addition to regulation of β-catenin, E-cadherin influences proliferation through 
other pathways as well. For example, engagement of E-cadherin either through direct cell-cell 
contact or through application of E-cadherin Fc coated beads in the absence of cell spreading 
enhances the number of cells in proliferative S-phase compared to controls.  This increase in 
proliferation was found to be dependent upon the activation of Rac1 and was lost upon E-
cadherin knock-down or treatment with the E-cadherin adhesion inhibitory antibody HECD1 
(Liu et al., 2006).  Such observations suggest that the E-cadherin mediated regulation of 
proliferation is controlled by signaling events that are directly dependent on its adhesive role 
in adherens junctions and not due to the steric blockage of cell spreading.  Knock-down of 
the adherens junction associated protein PLEKHA7 in Caco2 model intestinal epithelial cells 
results in increased cadherin-11, phopsho-p130CAS, cyclin D1, SNAI1, and c-Myc protein 
levels. Additional knock-down of E-cadherin or preventing the increase in cadherin-11 via 
shRNA reverses these changes (Kourtidis et al., 2015). Although the authors focus more on 
the mechanism through which PLEKHA7 itself participates in this signaling pathway, it is 
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Besides E-cadherin, other cadherins regulate cell proliferation through a variety of 
mechanisms. VE-cadherin inhibits cell growth by binding to a variety of growth factor 
receptors such as TGF-βR (Rudini et al., 2008) and VEGF-RII (Grazia Lampugnani et al., 
2003). In neural precursor cells located within the ventricular zone, N-cadherin knock-down 
results in reduced β-catenin activity and Akt phosphorylation, as opposed to the increased β-
catenin activity seen after knock-down of E-cadherin and VE-cadherin. The authors found 
that Akt prevented premature maturation of these neural progenitors (Zhang et al., 2013). 
Some unconventional or atypical cadherins can also modulate proliferative signaling. For 
example, cadherin-17 knock-down has been shown to result in decreased proliferation 
through reduced Erk phosphorylation (Lin et al., 2014). Even though these studies reporting 
detailed mechanisms by which cadherin family members other than E-cadherin regulate 
proliferation are limited, it is evident that these proteins participate in these biological 
responses. 
The role of desmosomal cadherins in proliferative signaling is complex and depends 
on the cell-type and/or cadherin involved. In intestinal epithelial cells, Dsc-2 knock-down 
results in increased proliferation through EGFR/β-catenin signaling (Kolegraff et al., 2011), 
while Dsg-2 knock-down reduces EGFR phosphorylation and inhibits proliferation 
(Kamekura et al., 2014). In line with these results, expression of Dsg-2 in the suprabasal 
layer of the epidermis in mice leads to epidermal hyperplasia. In western blots comparing 
transgenic and wild-type mouse skin, changes in the phosphorylation of several signaling 
mediators known to regulate proliferation were observed. These include, MAPK, Akt, PDK-
1, PTEN (inhibitory modification) and GSK-3β as well as increased PTEN, c-Myc, and NF-
κB protein levels  (Brennan et al., 2007). Exposure of intestinal epithelial cells to either IL-1β 
or TNF-α results in extracellular cleavage of Dsg-2 by the matrix metalloproteases MMP9 
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promotes proliferation through activation of Her2/3 signaling (Figure 1A) (Kamekura et al., 
2015). Analogous to Dsg-2 ectodomain cleavage, ADAM15 promotes extracellular cleavage 
of E-cadherin and the resulting fragment promotes Her2/3 heterodimerization and activation 
in breast cancer cell lines (Najy et al., 2008). The authors suggest that proliferation mediated 
by activation HER2/3 signaling could be associated with the oncogenic properties of soluble 
E-cadherin. Since these extracellular fragments affect both proliferation and adhesion, we 
have included this signaling mechanism as being adhesion dependent, despite the requirement 
for cadherin cleavage. Re-expression of Dsc-3 in Dsc-3-deficient lung cancer cell lines 
results in decreased basal levels of phosphorylated Erk1/2 and reduced proliferation (Cui et 
al., 2012). Thus the loss of Dsc-3 in lung cancer cells appears to activate pro-proliferative 
oncogenic Erk1/2 activity. These findings highlight a role of desmosomal cadherins that, 
analogous to classical cadherins, may control proliferation and invasion of tumor cells. 
B) Cadherin mediated regulation of apoptosis 
In addition to controlling proliferation, cadherins act as important mediators of 
apoptotic signaling. Much of the work into E-cadherin mediated regulation of apoptosis has 
been done in the context its role in cancer development and progression. E-cadherin 
homophilic engagement in HC11 mouse breast cancer cells enhances STAT3 
phosphorylation and disrupting this binding reduces pSTAT3 levels through activation of 
Rac1 leading to increased apoptosis (Figure 2A) (Arulanandam et al., 2009). This increased 
apoptosis and reduced STAT3 activation highlights disrupting E-cadherin engagement in 
breast cancer as a potentially attractive therapeutic strategy. Taken together with the findings 
of Liu et al., E-cadherin adhesion dependent activation of Rac1 appears to both enhance 
proliferation and reduce apoptosis, suggesting that this is one of the E-cadherin dependent 
mechanisms that are known to be suppressed in cancer. Expression of E-cadherin in lung, 
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direct interaction with the TNF-α Related Apoptosis Inducing Ligand (TRAIL) receptors, 
death receptors 4 and 5 (DR4/5) (Lu et al., 2014). Apoptosis sensitization was enhanced by 
E-cadherin adhesion and promoted formation of the Death Inducing Signaling Complex 
(DISC) in response to TRAIL treatment (Figure 2B) (Lu et al., 2014). This is an example of 
cadherins acting as scaffolds for transmembrane signaling proteins in addition to functioning 
as scaffolds for cytoplasmic/intracellular signaling proteins. E-cadherin adhesion deficient 
mutant proteins were used to show that E-cadherin mediated adhesion participates in the 
stimulation of notch signaling, resulting in increased expression of the anti-apoptotic protein 
Bcl-2 (Ferreira et al., 2012). These data provide examples showing that the adhesion state of 
E-cadherin, in addition to ensuring cell-cell cohesion, acts as a signal that modulates a variety 
of downstream signaling events to influence cellular homeostasis. Using mouse models 
expressing different chimeric cadherins containing portions of N-cadherin and E-cadherin it 
was shown that the extracellular domain of E-cadherin interacts with the Igf-1 receptor, 
which promotes activity of this receptor and survival of trophectoderm cells during blastocyst 
formation (Bedzhov et al., 2012). Through its robust regulation of both cell proliferation and 
cell death, E-cadherin functions to control key cellular outcomes that influence cellular 
homeostasis.  
The role of desmosomal cadherin mediated adhesion or junctional residence in 
apoptotic signaling is less well understood, but a few such mechanisms have been described. 
For example, expression of Dsg-2 in suprabasal cells of the murine epidermis increases NF-
κB and Bcl-XL protein levels. Keratinocytes derived from these mice display greater survival 
compared to cells derived from WT mice. These effects are enhanced by EGF treatment and 
are abolished by inhibition of NF-κB  (Brennan et al., 2007). As with proliferation, other 
classical cadherins in addition to E-cadherin participate in the regulation of apoptosis. In the 
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signaling as well as display increased apoptosis, proliferation, and migration and re-
expression of VE-cadherin in these cells reverses these effects (Giampietro et al., 2012). The 
authors found that altering the balance of normal VE-cadherin to N-cadherin expression 
levels leads to vascular elongation and increased angiogenesis (Giampietro et al., 2012). 
Following a series of co-expression experiments the authors suggest that VE-cadherin and N-
cadherin play similar but divergent roles in the regulation of proliferation, apoptosis, and 
migration of endothelial cells. 
 
C) Cadherin mediated control of cellular differentiation 
In addition to being important regulators of proliferation and apoptosis, cadherins also 
regulate cell differentiation in various contexts. Loss of E-cadherin in in vitro cultured murine 
embryonic stem cells decreases Klf4 and Nanog expression as well as pSTAT3 levels and 
interaction of STAT3 with the Nanog promoter (Hawkins et al., 2012). In another study using 
embryonic stem cells, treatment with E-cadherin adhesion blocking antibodies reduced 
expression of several transcriptional regulators as well as Tet1 and Esrrb (Segal & Ward, 
2017).  These reports highlight the importance of E-cadherin in the maintenance of the 
embryonic stem cell transcriptional program and in the ability of embryonic stem cells to 
maintain their pluripotency and stem cell properties. Overexpression of cadherin-11 in 
Xenopus embryos, inhibits cranial neural crest migration and is phenocopied by ADAM13 
inhibition. The authors found that ADAM13 cleaves cadherin-11 generating an extracellular 
fragment and treatment with this cadherin-11 extracellular fragment alleviates the effects of 
cadherin-11 overexpression and ADAM13 inhibition on cranial neural crest migration 
through binding of cadherin-11 (McCusker et al., 2009).  This is another example of the 
effects of cadherin extracellular fragments in modulation of cadherin mediated adhesion via 




This article is protected by copyright. All rights reserved. 
 
 
fragments functioning as signaling molecules that influence cadherin mediated adhesion. 
Generation of these fragments can be exquisitely regulated in order to facilitate specific 
functional outcomes like increased proliferation or migration of cells. 
Much of the research describing roles of cadherins in the regulation of differentiation 
are centered on the intricately regulated expression patterns of desmosomal cadherins, which 
play an essential role in ensuring appropriate epidermal differentiation.  This topic has been 
extensively discussed in previous reviews and will therefore not be detailed here (Green & 
Simpson, 2007; Nekrasova & Green, 2013). Exogenously expressed Dsg-1 co-
immunoprecipitates (Co-IPs) Erbin in normal human epidermal keratinocytes (NHEKs) 
(Harmon et al., 2013). Induction of differentiation in NHEKs leads to increased expression of 
many differentiation specific genes including loicrin and involucrin. However, after induction 
of differentiation in Erbin knock-down cells, these changes are all diminished, resulting in a 
lack of appropriate cellular differentiation. In differentiated wild-type NHEK cells pErk is 
predominantly confined to the basal layer, whereas after downregulation of Erbin, pErk was 
detected within the suprabasal cells of the epidermis. Dsg-1 expression facilitates co-
immunoprecipitation of Ras-Raf scaffold protein Shoc2 with Erbin and diminishes Erbin’s 
ability to Co-IP K-Ras (Harmon et al., 2013). It is important to note that expression of WT 
Dsg-1 reduces pErk1/2 levels by two thirds, whereas expression of Dsg-1 lacking the Erbin 
binding site decreases pErk1/2 levels by half. These data suggest that while the ability of 
Dsg-1 to bind Erbin plays an important role in its regulation of Erk1/2 phosphorylation, this 
signaling function is not exclusively mediated by Erbin binding (Harmon et al., 2013). These 
data suggest that desmogleins can modulate binding properties of other important signaling 
scaffold proteins, in addition to acting as a scaffold themselves. Abnormal differentiation of 
the suprabasal layers was observed in differentiated epidermal raft cultures derived from Dsg-
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keratinocytes increases pEGFR and pErk1/2 compared to control cells. Moreover, Erk1/2 
inhibition was found to reverse the effects of Dsg-1 knock-down on suprabasal epidermal 
differentiation (Getsios et al., 2009). Using NHEKs cultured in organotypic raft cultures, this 
same group showed that knock-down of the guanine nucleotide exchange factor Bcr or 
blockade of MAL/SRF-induced transcriptional regulation leads to reduced expression of 
multiple epidermal differentiation associated proteins. Re-expression of Dsg-1 in these cells 
rescues the loss of these differentiation markers (Dubash et al., 2013). These findings indicate 
that Dsg-1 dependent regulation of Erk1/2 phosphorylation, GEF Bcr, and MAL/SRF-
induced transcription are critical events in epidermal differentiation and their loss results in 
impairment of this vital process. Exposure of NHEKs to UVB prior to the induction of 
differentiation caused a dose dependent decrease in Dsg-1, Dsc-1, and multiple keratins as 
well as an increased pErk which is associated with delayed/impaired epidermal 
differentiation. Through overexpression and knockdown studies the authors show an 
influence of Dsg-1 in protection from the adverse effects UVB exposure on epidermal 
differentiation (Johnson et al., 2014). These example provide evidence for the importance of 
desmosomal cadherins in controlling epidermal differentiation which is vital for the defense 
properties of the skin.  
 
D) Other cadherin signaling events 
The role of cadherins in signaling extends beyond the basic homeostatic mechanisms 
of life, death, and differentiation. In fact, recent research into cadherin mediated signaling has 
begun to focus more on the roles that cadherins play in other signaling pathways. Since 
research into these aspects of cadherin signaling is in its infancy, this section will primarily 
focus on some isolated examples from various systems ranging from regulation of Schwann 
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(Parnaud et al., 2015). The rate and extent of myelination in the peripheral nervous system of 
E-cadherin knock-out mice is significantly reduced compared to wild-type animals which 
would result in impaired peripheral nervous system function. (Basak et al., 2015). E-cadherin 
together with neuregulin 1 increases phosphorylation of HER2, Akt, and Erk to facilitate 
myelination (Figure 2C) (Basak et al., 2015). Since very little is known about mechanisms 
that govern Schwann cell myelination, the finding that E-cadherin and neuregulin 1 work 
together to enhance this process is of great interest. Pernaud et al. observed that primary 
human pancreatic β-cells subjected to high glucose display a noticeable increase in insulin 
production when plated on E-cadherin Fc coated glass compared to controls. This effect is 
blocked by treatment with the E-cadherin adhesion blocking antibody DECMA-1 (Parnaud et 
al., 2015). These findings suggest that engagement of E-cadherin plays a role in insulin 
production in β-cells thereby controlling overall glucose metabolism. Furthermore, a recent 
study by Park et al. has also supported a role of E-cadherin in controlling glucose 
metabolism. Re-expression of E-cadherin in gastric cancer epithelial cells enhances oxidative 
phosphorylation and expression of glucose transporters. Glucose metabolism in cancer cells 
shifts from predominantly oxidative phosphorylation to anaerobic glycolysis during EMT, 
suggesting that loss of E-cadherin may play a role in this metabolic shift. These effects are 
reduced following NF-κB knock-down, suggesting that NF-κB participates in promoting 
oxidative phosphorylation upon E-cadherin re-expression in cancer cells (Park et al., 2017). 
Using MCF10A human mammary epithelial cells, Bays et al. showed that application of 
extracellular force to endogenous E-cadherin through the use of E-cadherin Fc coated 
magnetic beads stimulates AMPK activation as well as increased phosphorylation of MLC, 
vinculin, and CrkL. This was associated with reinforcement of the actin cytoskeleton and 
enhanced barrier function. Additionally, application of force to E-cadherin increases glucose 
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AMPK, and Lkb1 as well as E-cadherin adhesion blocking antibody treatment (Bays et al., 
2017).  Together, these results suggest that, in addition to its roles in adhesion and regulation 
of epithelial barrier properties, E-cadherin contributes to nutrient signaling that has not been 
fully explored. Additionally, the work of Bays et al. highlights the diversity of cadherin 
mediated signaling mechanisms that are dependent on its mechanotransduction properties. 
Loss of E-cadherin is known to play a role in the epithelial to mesenchymal transition (EMT) 
and the subsequent increased invasiveness and dissemination of metastatic cancer cells. 
Knock-down of E-cadherin in A549 non-small cell lung carcinoma (NSCLC) cells increases 
invasiveness as well as enhances expression of multiple MMPs and transcriptional regulators. 
These effects of E-cadherin knockdown were reversed by MEK inhibition (Bae et al., 2013). 
Such findings suggest that the contribution of E-cadherin loss to epithelial - mesenchymal 
transition (EMT) and tumor invasion are at least partly mediated through activation of 
MEK/Erk signaling.  
Analogous to E-cadherin, other classical cadherins contribute to diverse signaling 
event. For example, extracellular cleavage of N-cadherin on microglial cells by ADAM10 
and MMP9 and treatment of cultured primary microglial cells with the resulting protein 
fragment increases nuclear NF-κB translocation as well as release of TNF-α, MMP9, and 
MCP-1 indicating increased microglial activity (Conant et al., 2017).  In light of the many 
examples of N-cadherin participating in signaling mechanisms in epithelial, endothelial, and 
neuronal cells, it will be of great interest to further explore and define the overall signaling 
repertoire of this protein and its control of cellular functions. 
There have been recent examples of cadherin mediated signaling that involve their 
residence in multi-protein complexes other than their traditional junctions. For example, 
Labernadie et al. showed that Cancer Associated Fibroblasts (CAFs) exert forces on A431 
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N-cadherin/E-cadherin junctions with the A431 cells. These junctions can withstand 
mechanical forces and are involved in mechanotransdution cross-talk between cancer cells 
and CAFs (Labernadie et al., 2017). Such cadherin mediated mechanotransduction influences 
CAF polarization and directional migration of cancer cells in three-dimensional cultures led 
by CAF movement. E-cadherin was required for the transduction of force between these two 
cell types.  Thus, classical cadherins can participate in heterotypic junctions that can 
withstand force and these junctions can have an impact on cellular outcomes (Labernadie et 
al., 2017). In endothelial cells, it was shown that the transmembrane domain (TMD) of 
Notch1 forms a mechanosensory complex containing the transmembrane tyrosine 
phosphatase leukocyte common-antigen related (LAR), GEF Trio, and Rac1, which 
participate in the activation of Rac1 and functions to regulate the formation of adherens 
junctions and endothelial permeability. This complex is targeted to adherens junctions 
through binding of the Notch1 TMD with VE-cadherin (Polacheck et al., 2017). 
Tsang et al. examined the effects of Dsg-3 on junctional and cytoskeletal components 
and observed that knock-down of Dsg-3 in HaCaT cells results in decreased expression of 
adherens junction, desmosome, and actin cytoskeleton associated proteins that was linked to 
impaired development and function of intercellular junctions and cell polarization. In 
addition, Dsg-3 knock-down cells displayed decreased β-catenin tyrosine phosphorylation as 
well as several other distinct effects including diminished re-integration of junctional E-
cadherin and β-catenin following calcium switch supporting its role in the assembly of 
intercellular junctions in HaCaT cells.  This loss of Dsg3 impaired the formation of adherens 
junctions and E-cadherin dependent Src activation (Tsang et al., 2012a; Tsang et al., 2012c). 
On the converse overexpression of Dsg-3 in HaCaT and A431 cells increases the number of 
actin protrusions and the rate of actin turnover as well as activation of several Rho family 
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combined with Rac1 inhibition, Dsg-3 overexpression increases A431 cell migration (Tsang 
et al., 2012a). The authors also described interaction between a non-junctional pool of Triton 
X-100 soluble Dsg-3 and E-cadherin in a calcium, p120, and plakoglobin dependent manner 
(Tsang et al., 2012c). Such observations suggest that Dsg-3 (and potentially others 
desmogleins) play a much larger role in overall junctional and cytoskeletal regulation and the 
subsequent control of cellular polarization and tissue remodeling than previously appreciated. 
 
E) Cadherin mediated signaling in the context of disease  
Cadherin mediated signaling mechanisms have been shown to play an important role 
in multiple disease states and pathologies. One of the most well studied examples is in the 
context of cancer. A number of previous reports have addressed cadherin dependent 
regulation of cancer pathogenesis and progression that involves control of cellular 
proliferation, apoptosis, invasiveness, metabolism, and metastasis in the context of this 
disease (Conacci-Sorrell et al., 2002; Cavallaro & Christofori, 2004; Jeanes et al., 2008; 
Onder et al., 2008; Solanas et al., 2008; Maher et al., 2009; Bae et al., 2013; Lu et al., 2014; 
Park et al., 2017). Although E-cadherin is a classic example of cadherin mediated signaling 
in cancer, N-cadherin, VE-cadherin, desmosomal cadherins, and other cadherins have also 
been shown to participate in oncogenic signaling in cancer pathogenesis. Since we have 
mentioned examples of cadherin signaling in the context of oncogenesis above, and this topic 
has been detailed in previous reviews, we focus on cadherin contribution to other disease 
mechanisms in this section. 
We will in large part address the role of cadherin signaling in the autoimmune skin 
diseases pemphigus vulgaris (PV) and pemphigus foliaceus (PF). Several signaling 
mechanisms have been implicated in the pathobiology of pemphigus. Pemphigus vulgaris and 
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and Dsg-1 respectively (Mao et al., 2011; Schulze et al., 2012). Studies using multiple 
systems have shown that the use of monoclonal antibodies targeting desmogleins can 
recapitulate pemphigus pathology (Schulze et al., 2012; Bektas et al., 2013). However, the 
contribution of desmogleins to these signaling events remains incompletely understood 
(Chernyavsky et al., 2007). We will highlight some key examples of signaling caused by 
pemphigus autoantibodies because this field of study has been previously reviewed more 
comprehensively (Sharma et al., 2007; Schmidt & Waschke, 2009; Spindler & Waschke, 
2014). Following 48 hours of treatment with PV autoantibodies, mouse keratinocytes display 
reduction in nuclear localization of plakoglobin (Pg). Plakoglobin is a member of the 
armadillo family of proteins and is the most closely related protein to the famous signaling 
mediator β-catenin. Plakoglobin is a critical component of the desmosomal plaque and 
directly binds to the intracellular tails of desmogleins and desmocollins. After prolonged PV 
autoantibody treatment, keratinocytes display noticeably increased proliferation, c-Myc 
expression, and c-Myc nuclear localization, which was shown to be reversed after 
plakoglobin knock-out. Analogous increased proliferation is also seen in human PV patient 
skin samples (Williamson et al., 2006). NHEKs treated with PV autoantibodies display 
internalization and depletion of Dsg-3, which are prevented by p38MAPK inhibition (Jolly et 
al., 2010). It was later shown that in response to patient derived PV autoantibody treatment 
p38MAPK phosphorylation occurs prior to the activation of EGFR resulting in blister 
formation. The PV autoantibody treatment causes an increase in pErk1/2, which is enhanced 
by inhibition of either p38MAPK or EGFR phosphorylation (Bektas et al., 2013). These 
observations suggest that some of the changes in signaling mediators observed upon PV 
autoantibody treatment can be antagonistic in nature. For example, the PV autoantibody 
induced increases in p38MAPK and EGFR dampening the increase in pErk1/2 caused by the 
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causes PV phenotypes) treatment causes endocytosis of EGFR, which is prevented by 
p38MAPK inhibition resulting in reduced blister formation. Exposure of NHEKs with PV 
autoantibodies leads to Dsg-3 internalization and overall loss of the protein. These effects are 
reduced by pre-treatment with inhibitors of either p38MAPK or EGFR or knock-down of 
EGFR. The functional outcome of EGFR inhibition in these models was prevention of the 
loss of Dsg-3 mediated adhesion resulting in decreased blister formation (Bektas et al., 2013).  
Dysregulation of apoptosis is also known to be important in PV pathobiology.  A 
mouse model often used to study these diseases is referred to as a passive transfer mouse, in 
which IgG or serum derived from PV or PF patients is injected into the blood stream of 
embryonic mice after which the mice develop symptoms and clinical manifestations of the 
parent disease. PV passive transfer mice show higher Bax and lower Bcl-2 protein levels, as 
well as increased caspase-3 and -9 activity. In addition, the PV transfer treated mice have 
enhanced phosphorylation of m-TOR and Src as well as increased blister formation and 
apoptosis, all of which are abolished or reduced by FAK inhibition (Gil et al., 2012). 
Increased apoptosis was observed in the epidermis of PF passive transfer mice which led to 
the development of experimental PF. These effects were reversed using pan-caspase or 
caspase-3 selective inhibitors (Li et al., 2009). In biopsy samples derived from the skin 
surrounding the injection site of PF passive transfer mice, Lee et al. observed an increase in 
phospho-p38MAPK in two peaks following treatment. The authors also described apoptosis 
execution beginning 30 hours post treatment and increasing in severity over time, which is 
prevented by p38MAPK inhibition. Only inhibition of the first p38MAPK peak but not the 
second prevented blister formation in these mice (Lee et al., 2009). These data suggest that 
this first burst of p38MAPK activation mediates blister formation in PF. In the basal cells of 
PV passive transfer mice, Pretel et al. describe increased phosphorylated Her family growth 
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all inhibited by EGFR inhibitor treatment. The authors also found increased betacellulin, 
TGF-α, and EGF in these cells. Pre-treatment with an EGFR inhibitor, a Src kinase family 
inhibitor, rapamycin, or pan-caspase inhibitors all prevent the apoptosis and other clinical 
manifestations normally seen in PV passive transfer mice (Pretel et al., 2009). These data 
suggest that the increased apoptosis seen in response to pemphigus autoantibody treatment is 
necessary for the development of clinical symptoms. Passive transfer mice have proven 
useful in exploring non-apoptotic aspects of pemphigus related signaling as well. Using 
passive transfer of AK23 (monoclonal mouse anti-Dsg-3 antibody), Schulze et al. observed 
increased activation or expression of several signaling mediators that promote proliferation. 
They also observed decreased expression of total and phospho p38MAPK, Dsg-1/2, Dsg-3 
and EGFR. These AK23 passive transfer mice developed typical blistering and other 
symptoms associated with clinical PV (Schulze et al., 2012). Ex vivo treatment of human skin 
tissue with PV or PF autoantibodies results in blister formation that is repressed by enhanced 
RhoA signaling. In HaCat cells, inhibition of p38MAPK or activation of Rho family 
members prevents the disruption of several desmosomal proteins and E-cadherin normally 
seen in response to PV autoantibody treatment. As discussed above, disruption of these 
proteins is important to the development of blistering and other PV or PF symptoms. 
Treatment of HaCaT cells with PV or PF autoantibodies also results in reduced active RhoA, 
which is prevented by p38MAPK inhibition (Waschke et al., 2006). These data suggest that 
inhibition of RhoA occurs following p38MAPK activation and is an important step in 
pemphigus pathobiology through preventing RhoA activity from inhibiting the disruption of 
desmosomal proteins and E-cadherin. Using a panel of PV monoclonal antibodies, only those 
that cause a loss of intercellular adhesion activate p38MAPK. The authors also found that 
inhibition of p38MAPK prevents Dsg-3 internalization and depletion in response to the PV 
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adhesion through internalization and loss of the desmogleins themselves may be a critical 
factor in pathogenicity of these autoantibodies. 
Cadherin mediated signaling has been shown to participate in other disease states 
besides cancer and pemphigus, but these are far fewer.  For example, Dsg-1 mRNA and 
protein expression is reduced in eosinophilic esophagitis (EoE), that has been associated with 
reduced barrier integrity and adhesion (Sherrill et al., 2014a). These effects are recapitulated 
by Dsg-1 knock-down of cultured esophageal epithelial cells. Dsg-1 knock-down promotes 
pro-inflammatory transcriptional responses as analyzed by genome-wide by RNAseq 
(Sherrill et al., 2014a). Both Dsg-1 knock-down in cultured esophageal epithelial cells and in 
human EoE patient samples display noticeably increased mRNA expression of the integrin 
ligand protein periostin compared to controls (Sherrill et al., 2014a). Periostin is known to be 
highly expressed in EoE (Dellon et al., 2016; Politi et al., 2017).  This data suggests that 
increased periostin expression after loss of Dsg-1 may contribute to the pathobiology of EoE. 
Samples from human patients with striate palmoplantar keratoderma (SPPK) arising from 
mutations in Dsg-1 display increased Erk activity and reduced Dsg-1, loricrin, and keratin-10 
expression.  These samples also display increased interaction of Shoc2 with K-ras and 
reduced interaction of this protein with Erbin (Harmon et al., 2013). Combined with the 
pemphigus examples above, desmogleins play a key role in the pathobiology of a number of 
disorders that include skin diseases and cancer. 
 
F) Cadherin intracellular fragment signaling 
The findings we have described thus far in this review highlight the diversity and 
importance of cadherin mediated signaling. However, most of these mechanisms are either 
dependent on or in some way influenced by changes in cadherin mediated adhesion in 
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mediated signaling mechanism that do not appear to be influenced by changes in cadherin 
adhesion. Most of these mechanisms are based on intracellular cadherin cleavage and the 
generation of a functional protein fragment. For example, E-cadherin can be cleaved 
intracellularly by gamma secretase resulting in generation of the E-cadherin C-Terminal 
Fragment 2 (CTF2) (Marambaud et al., 2002). Expression of CTF2 results in its nuclear 
localization and increased proliferation, which are both enhanced by co-expression with 
p120. E-cadherin CTF2 promotes Kaiso mediated transcriptional regulation and is able to Co-
IP both with Kaiso and p120 (Figure 1B) (Ferber et al., 2008). In line with the E-Cadherin 
CTF2, expression of N-cadherin c-terminal fragment 2 (CTF2) leads to N-Cadherin CTF2 
nuclear localization and increased expression of β-catenin and cyclin D1 as well as increased 
emigration of neural crest cells from the developing neural tube in quail embryos (Shoval et 
al., 2007). In response to UV induced apoptosis in keratinocytes, desmoglein-1 is cleaved 
intracellularly by caspases-3 and -7 and knock-down of desmoglein-1 protects cells from UV 
induced apoptosis (Dusek et al., 2006). We have recently shown that in response to TNF-α 
and IFN-γ as well as TRAIL treatment, Dsg-2 undergoes intracellular cleavage that is 
mediated by caspase-8. The resultant Dsg-2 intracellular fragment (Dsg-2 ICF) sensitizes 
intestinal epithelial cells to apoptosis through increased expression of the anti-apoptotic Bcl-2 
family members Bcl-XL and MCl1 (Yulis et al., 2018). Taken together, these findings 
highlight the importance of cadherin intracellular fragments serving as key signaling 
mediators. 
 
G) Cadherin signaling in cells lacking intercellular adhesion 
There are also a few examples of cadherin mediated signaling that remain intact in 
cells lacking intercellular adhesion. In immortalized untransformed human mammary 
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expression as well as reduced expression of cytokeratin 18, indicative of an epithelial to 
mesenchymal transition. However, this was not seen after expression of adhesion blocking 
dominant negative E-cadherin, indicating that the E-cadherin dependent signaling 
mechanisms preventing cells from undergoing EMT in this system are independent of E-
cadherin’s intercellular adhesion properties (Onder et al., 2008). In addition, E-cadherin 
knock-down results in increased motility, invasiveness, and reduced sensitivity to apoptosis, 
all of which are rescued by expression of the adhesion blocking E-cadherin dominant 
negative protein (Onder et al., 2008). While organoids generated from primary mammary 
epithelial cells derived from mice with inducible E-cadherin knock-out displayed a normal 
epithelial phenotype upon E-cadherin knock-out, the cells displayed a more classically 
mesenchymal phenotype. In spite of this phenotype however, few cells disseminate out as 
single cells and therefore do exhibit classic invasive properties. The transcription factor 
Twist1 has been suggested to play an active role in promoting EMT through regulation of E-
cadherin and other mediators. Primary mammary epithelial cell organoids derived from mice 
with overexpression of Twist1 exhibit single cell dissemination, which was inhibited upon E-
cadherin knock-down (Shamir et al., 2014). These data support a role of E-cadherin – Twist 
signaling in the development of metastatic potential cells. Thus, E-cadherin signaling 
modulates cancer phenotypes through signaling mechanisms that remain intact even in the 
absence of intercellular adhesion. Similarly, in Xenopus embryos knock-down of cadherin-11 
inhibits cranial neural crest cell migration and this effect is rescued by expression of 
cadherin-11 lacking the extracellular domain. However, expression of cadherin-11 lacking 
the β-catenin binding domain or the transmembrane domain does not rescue this loss of 
cranial neural crest cell migration. These effects are also reversed by supplementation with 
recombinant Rho family small GTPases or the Rho GEF Trio (Kashef et al., 2009). Although 
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understood, these examples open the door to a new frontier of possibilities regarding the 
breadth of cadherin mediated signaling. 
 
Conclusion    
 The cadherin family of transmembrane proteins serve as important intercellular 
adhesion molecules. Over the years, appreciation of their function as critical signaling 
mediators has been steadily growing. Classical, desmosomal, atypical, and unconventional 
cadherins all participate in many signaling cascades that influence proliferation, apoptosis, 
and differentiation in a number of tissues and cell types as well as in disease. In more recent 
years, the critical roles that cadherins play in the regulation of non-homeostatic cellular 
functions have emerged.  Dysregulation of cadherin mediated signaling results in disease 
states encompassing epithelial barrier defects, inflammation, and neoplasia. While great 
pioneering research has been performed, we have only just begun to understand the extent to 
which cadherins participate in signaling events. Due to their importance in intercellular 
adhesion, most of the cadherin mediated signaling described thus far is directly influenced by 
either the junctional residence or the adhesive state of the cadherin itself. Further study of 
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Graphical Abstract) Modalities of cadherin mediated signaling:  Cadherins have been 
shown to participate in many diverse signaling pathways and mechanisms.  Not only is the 
range of functional outcomes that cadherins regulate wide, the number of different types of 
mechanisms that cadherins participate in to mediate their signaling is also impressive.  
A) Many times, cadherins themselves act as scaffolds for important signaling events and the 
ability of the cadherin to participate in these signaling mechanisms is often dependent upon 
their participation in cadherin mediated adhesion.   
B) Other mechanisms requiring cadherin mediated adhesion include cadherin protein 
association with other transmembrane signaling proteins and receptors.   
C+D) There are several reports of cadherin mediated signaling that requires the formation of 
stable cadherin protein fragments via regulated proteolytic cleavage.  Most of these 
mechanisms require cadherin extracellular fragment generation and often times both 
stimulate receptor signaling pathways and interfere with cadherin mediated adhesion (C).  
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generation (D).  These mechanisms often entail binding of the intracellular fragment to a 
cytoplasmic signaling partner, nuclear re-localization, and regulation of gene transcription. 
 
 
Figure 1) Examples of cleavage dependent cadherin mediated signaling.  A growing 
number of reports have shown that cadherin protein fragments generated through regulated 
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A) Many of these mechanisms are dependent upon cadherin extracellular fragment 
generation.  These usually influence signaling of transmembrane receptors and/or cadherin 
mediated adhesion in a paracrine and/or autocrine manner.  The extracellular fragment of 
Dsg2 has been shown to participate in both of these activities interfering with Dsg2 
extracellular adhesive binding and increasing proliferation through stimulation of the Her2 
and Her3 receptors (Kamekura et al., 2015).   
B) Cadherin intracellular fragments also mediate important signaling events.  An example of 
this is the enhancement of E-cadherin C-Terminal Fragment 2 (CTF2) nuclear localization 











Figure 2) Examples of cadherin mediated signaling dependent on junctional residence 
and adhesive state.  Cadherin cytoplasmic tails can act as scaffolds for intracellular signaling 
molecules thereby promoting distinct signaling pathways under various conditions.  These 
scaffolding functions are often dependent upon the following:  
A+B) The adhesive state of the cadherin or C) the presence of the cadherin within a stable 
junction.  Examples of these types of mechanisms include activation of Rac1 and Stat3 
signaling through E-cadherin adhesive binding leading to repression of apoptosis 
(Arulanandam et al., 2009) or reduced peripheral nervous system myelination in the absence 
of E-cadherin (Basak et al., 2015).  There have even been a few reports of cadherin adhesive 
binding leading to the cadherin acting as a scaffold for and enhancing the activity of 
transmembrane signaling receptors such as the receptors for TNF-α Related Apoptosis 
Inducing Ligand (TRAIL), Death Receptors 4 and 5 (DR4 and 5) leading to enhanced Death 















Proliferation E-Cadherin β-catenin TCF/LEF; Fibronectin (Solanas et al., 
2008) 
   TCF/LEF; β-catenin (Maher et al., 
2009) 
  β-catenin Hippo; YAP (Kim et al., 2011b) 








) HER2/3 ErBb (Najy et al., 2008) 
 (CTF2
#
) p120; Kaiso Kaiso
†
 (Ferber et al., 
2008) 
  EGFR EGF
‡
; Stat5; ERK (Perrais et al., 
2007) 





p120; Src; p130 CAS; c-Myc; 
FAK; SNAI1;  
(Kourtidis et al., 
2015) 
     
 N-Cadherin β-catenin Akt (Zhang et al., 2013) 




; TBX6 (Zhang et al., 2013) 
 (CTF2
#
)  Cyclin D1; β-catenin (Shoval et al., 
2007) 
     





Smad1/5, 2, 3 
(Rudini et al., 
2008) 







Lampugnani et al., 
2003) 












β-catenin PI3K; FoxO1; Akt; SOD
‡
; 
β-catenin; Caspase-3; FGF-2; 
MMP3; PDGFRA; ANGPT2; 
FRS-2α 
(Giampietro et al., 
2012) 
     
 Cadherin-17  Ras; Raf; MEK; Erk; 
Integrin β1, β4, β5; p21; p53; 
(Lin et al., 2014) 
     
 Dsg-2  EGFR; Dsc-2; Histone H3; 
Src; Erk1/2 





  MAPK; Akt; PDK-1; GSK-3β; 
PTEN; c-Myc; NFκB; 
MEK1/2; p90RSK; Raf; Stat3; 
Bcl-XL 




) HER2/3 S6; mTOR; MAPK; Akt; 
Erk1/2 
(Kamekura et al., 
2015) 
     
 Dsc-2  EGFR; CD44; Akt; β-catenin
†
 (Kolegraff et al., 
2011) 
     
 Dsc-3  Erk1/2 (Cui et al., 2012) 
     
Apoptosis E-Cadherin DR4/5 DISC [complex formation] (Lu et al., 2014) 
   Stat3; Rac1; Cdc42 (Arulanandam et 
al., 2009) 
   Notch; Bcl-2 (Ferreira et al., 
2012) 
  Igf-1r Igf-1
‡ 
(Bedzhov et al., 
2012) 










vimentin; fibronectin  






β-catenin PI3K; FoxO1; Akt; SOD
‡
; 
β-catenin; Caspase-3; FGF-2; 
MMP3; PDGFRA; ANGPT2; 
FRS-2α 
(Giampietro et al., 
2012) 
     
 Dsg-1  Caspase-3 (Dusek et al., 2006) 




  MAPK; Akt; PDK-1; GSK-3β; 
PTEN; c-Myc; NFκB; 
MEK1/2; p90RSK; Raf; Stat3; 
Bcl-XL 
(Brennan et al., 
2007) 
     
Differentiation E-Cadherin  Klf4; Nanog; Stat3; Erk1/2; 
Akt; N-cadherin 
(Hawkins et al., 
2012) 
   Stat3; Tet1; Esrrb; Tbx3; 
Nanog; Klf4; Nr0B1; Nr5a2; 
Erk1/2 
(Segal & Ward, 
2017) 
     
 Dsg-1 Erbin; Shoc2 Erk1/2; K-Ras; loricrin; 
keratin-10 
(Harmon et al., 
2013) 
   EGFR; Erk1/2; Lamin A/C; 
keratin-10; desmocollin-1; 
fillagrin; loricrin; c-Raf; 
Mek1/2; EphA2; ErbB2 




 desmocollin-1; MAL; SRF; 
keratin-10; keratin-1; loricrin 
(Dubash et al., 
2013) 
     


















? (McCusker et al., 
2009) 






















 β-catenin NFκB; Wnt; c-Myc; IκBα; 
GLUT1; GLUT3; GLUT4 
(Park et al., 2017) 
  Lkb1; 
AMPK
* 
MLC; Vinculin; CrkL; Abl; 
RhoA 
(Bays et al., 2017) 
   EGFR; Erk; ZEB1; 
N-cadherin; CDH1; Twist; 
Slug; ZEB1; MMP2; p53; 
GSK3β 




  Twist; β-catenin; 
Cytokeratin-8; N-cadherin; 
vimentin; fibronectin  
(Onder et al., 2008) 
  Twist1
◊
 N-cadherin; αE-catenin; 
β-catenin 




 Afadin; Nectin-2; Nectin-3 (Labernadie et al., 
2017) 
















NFκB; Iba-1; TNF-α; MMP9; 
MCP-1 
(Conant et al., 
2017) 
     
 VE-cadherin Notch-1; 
LAR; Rac-1; 
TRIO 
? (Polacheck et al., 
2017) 
     
 Dsg-1  periostin (Sherrill et al., 
2014b) 
     
 Dsg-3 E-Cadherin; 
Actin; Rac1; 
RhoA; Cad42 
Src; p120; β-catenin; MLC (Tsang et al., 
2012d) 












PKP2; desmoplakin; PKP1; 
Src;  
(Tsang et al., 
2012b) 
     
 Cadherin-11 β-catenin GEF-Trio; Rho; Rac; Cdc42 (Kashef et al., 
2009) 
*Interaction is inferred but not directly demonstrated 
†
Inferred through effects on promoter based reporter activity assay 
‡
The cadherin influences the outcome of this mediator’s signaling, but is not 
activating or repressing this mediator directly 
#
Cadherin cleavage fragment shown to mediate this signaling 
◊
Although no interaction is shown or inferred, the cadherin directly modulates the 
signaling of this protein 
▪
Inhibition of this protein enhances effects of cadherin mediated signaling, although 
no direct binding was detected or inferred 
